Adverse drug reactions in patients admitted on Internal Medicine wards in a district and Regional Hospital in Uganda

African Health Sciences

Volumn 11, Issue 1, 2011, Pages 72-78

  Tumwikirize, Winifred A ^a,b   Ogwal Okeng, J W ^a   Vernby, A ^b   Anokbonggo, W W ^a   Gustafsson, L L ^c   Lundborg, S C ^b  

^a MAKERERE UNIVERSITY   (Uganda)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adverse drug reactions; Hospitalization; Medical wards

Indexed keywords

ACETYLSALICYLIC ACID; AMPHOTERICIN B; AMPICILLIN; ANTIINFECTIVE AGENT; ANTIPARASITIC AGENT; CHLOROQUINE; COTRIMOXAZOLE; DOXYCYCLINE; IBUPROFEN; INDOMETACIN; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; METRONIDAZOLE; PENICILLIN G; PREDNISONE; QUININE;

ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; FEMALE; GASTROINTESTINAL DISEASE; HEARING DISORDER; HEART ARRHYTHMIA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTERNAL MEDICINE; LENGTH OF STAY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MUSCULOSKELETAL DISEASE; NUTRITIONAL DISORDER; OBSERVATIONAL STUDY; PATIENT ASSESSMENT; PERIPHERAL NEUROPATHY; RESPIRATORY TRACT DISEASE; SKIN DISEASE; SKIN MANIFESTATION; UGANDA; VISUAL DISORDER;

ADULT; AGE DISTRIBUTION; ANTIPARASITIC AGENTS; DRUG THERAPY; DRUG TOXICITY; FEMALE; HOSPITAL UNITS; HOSPITALIZATION; HOSPITALS, PUBLIC; HUMANS; INTERNAL MEDICINE; LONGITUDINAL STUDIES; MALE; MORBIDITY; PATIENT ADMISSION; UGANDA;

EID: 79953804322     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Begaud B. Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol. 2000 May;56(2):181-6.
2. Dormann H, Neubert A, Criegee-Rieck M, Egger T, Radespiel-Troger M, Azaz-Livshits T, et al. Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med. 2004 Jun; 255(6):653-63.
3. Hallas J, Gram LF, Grodum E, Damsbo N, Brosen K, Haghfelt T, et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol. 1992;33(1):61-8.
4. Pouyanne P, Haramburu F, Imbs JL, Begaud B. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres. BMJ. 2000 Apr 15;320(7241):1036.
5. Mjorndal T, Boman MD, Hagg S, Backstrom M, Wiholm BE, Wahlin A, et al. Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf. 2002 Jan-Feb;11(1):65-72.
6. von Euler M, Eliasson E, Ohlen G, Bergman U. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization. Pharmacoepidemiol Drug Saf. 2006 Mar;15(3):179-84.
7. Mehta U, Durrheim DN, Blockman M, Kredo T, Gounden, R., Barnes KI. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study. Br J Clin Pharmacol. 65(3):396-406.
8. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a metaanalysis of prospective studies. JAMA. 1998 Apr 15;279(15):1200-5.
9. Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol. 1998 Mar;45(3):301-8.
10. Gholami K, Shalviri G. Factors associated with preventability, predictability, and severity of adverse drug reactions. Ann Pharmacother. 1999 Feb;33(2):236-40.
11. Camargo AL, Cardoso Ferreira MB, Heineck I. Adverse drug reactions: a cohort study in internal medicine units at a university hospital. Eur J Clin Pharmacol. 2006 Feb;62(2):143-9.
12. Edwards IR, Biriell C. Harmonisation in pharmacovigilance Drug Saf. 1994;10:93-102.
13. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981 Aug;30(2):239-45.
14. Dormann H, Muth-Selbach U, Krebs S, Criegee-Rieck M, Tegeder I, Schneider HT, et al. Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf. 2000 Feb;22(2):161-8.
15. WHO. International Classification of Diseases, Version 10; 2007a.
16. Meyboom RH, Lindquist M, Egberts AC. An ABC of drug-related problems. Drug Saf. 2000 Jun;22(6):415-23.
17. WHO. Adverse Reaction Terminology, December 2006. The Uppsala Monitoring Centre. World Health Organization; 2006.
18. WHO. Guidelines for ACT Classification and DDD assignment. 2007b.
19. Schumock GT, & Thornton, J. P. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992;27:538.